[ad_1]
During the opening of Expo 2020 Dubai, the world’s largest exhibition, Novartis, the world’s leading pharmaceutical company, appeared in the Swiss Pavilion in the Opportunity Zone. Novartis has been ranked among the top R&D investment companies in the world, and promised to showcase the most promising scientific frontiers, the most transformative medical innovations, and the most important healthcare needs in October.
Based on the theme of Expo 2020 Dubai “Connect ideas and create the future”, Novartis aims to increase the global awareness of Breast Cancer Awareness Month by linking the ideas of various relevant stakeholders to encourage and advocate for a better future for breast cancer patients.At their experience exhibition, Novartis, which has been committed to reimagining medicine, hosted an exclusive panel discussion on Friday night, October 8th.dayThis brings together top stakeholders, including Marie-Andrea Gamache, Regional Head of Oncology MEA of Novartis, Professor Humaid AlShamsi, President of the UAE Oncology Society, Executive Beneficiary Support Services-Friends of Cancer Sabrina Zucchello, Majed Mohammed, International Union for Cancer Control (UICC) and breast cancer survivor Julie Rihani.
The UAE’s healthcare sector is ready to continue its rapid expansion and implement bold and critical strategies aimed at solving the most critical issues facing patients and medical professionals in the country. Cancer care is well placed on the national agenda, and the UAE is working hard to shape and provide comprehensive cancer care, including prevention, diagnosis, treatment and palliative care.
When welcomed by HE Massimo Baggi, Swiss Ambassador to the United Arab Emirates and Bahrain and Francis Bouchard of Novartis Oncology, our team members participated and discussed the unique challenges faced by cancer patients-statistics in 2020 Among them, 2.3 million women worldwide have been diagnosed with breast cancer, of which 685,000 died*. As of the end of 2020, 7.8 million women have been diagnosed with breast cancer in the past 5 years, making it the most common cancer in the world*.
Professor Humaid AlShamsi, President of the UAE Oncology Society, outlined the ways in which cancer patients continue to face one of the biggest challenges in life. “We are honored to come to the Swiss Pavilion today to raise the awareness of the breast cancer community. We are committed to supporting and promoting multi-dimensional care of cancer patients throughout the United Arab Emirates, bringing all the major stakeholders together, working together and working hard. Healing. Our evening’s theme “Connect minds and save lives” is our determined voice because we work together to change the concept of breast cancer disease. The UAE is leading this effort and taking solid steps forward in the fight against breast cancer Therefore, we hope to conduct a more in-depth analysis of early breast cancer detection and increase awareness of detection, especially when we see more young people who have been diagnosed with this disease.”
Marie-Andrea Gamache, Regional Head of Oncology MEA, stated that the relationship between pharmaceutical companies, doctors, caregivers and patients has undergone major changes, and commented: “Our goal at Novartis and today’s activities is to never leave any The patients are behind. Continuous cooperation with our stakeholders to raise the awareness that our breast cancer community needs is the key. The voices of these patients have always been there, but our role at Novartis is to hear these voices and work for the cure As we move forward as a member of the breast cancer field, we need to ensure that we identify problems and face challenges with our community. In recent years, we have turned to personalized medicine and treatment in the pipeline of breast cancer dedication and cure. Innovation. By raising awareness at all levels (from government to patients, organizations and even the media), this joint effort is considered successful when we work together to change breast cancer. Keep our passion for a better tomorrow.”
Wael Omran, General Manager of Oncology in the Gulf Region, said: “Novartis Oncology is committed to innovating and improving cancer treatment methods and ensuring that cancer patients, their caregivers and their families understand the support they can get. “Today’s event is at the Swiss Pavilion in 2020. Dubai World Expo 2010 provided an opportunity to link national scientific societies such as the United Arab Emirates Society of Oncology (EOS), local patient rights groups such as Friends of Cancer Patients (FOCP), and The Union’s ideas to the International Cancer Control (UICC), which is The largest international cancer membership organization. The goal is to share experiences and raise awareness of the needs of breast cancer patients and those affected by it. This is a milestone in our bold ambition to reimagine medicine in the Bay Area by transforming cancer care in our region,” he added.
Majed Mohammed, Executive Beneficiary Support Service-Friends of Cancer Patients (FOCP), said: “We are very happy to be here today because FOCP continues to strengthen its efforts to build awareness and education around the journey of cancer patients. Patient advocacy, patient access Community awareness is our three pillars. This is a joint effort between our stakeholder communities to improve the education of today’s breast cancer community. We are committed to allowing our patients to speak their ideas in a safe space. Express their concerns and be able to participate in all aspects of their cancer journey. In recent years, the UAE has become more advanced in dealing with the prevention, diagnosis and treatment of breast cancer while collaborating with the right partners. We focus on encouraging more More financial, spiritual and psychological support, which in turn will affect the willingness of patients to recover. We want to ensure that our patients are truly alive, not just alive.”
Sabrina Zuchero The International Union for Cancer Control (UICC) stated: “Breast cancer is now the most common cancer in the world and the leading cause of death from cancer in women worldwide. Now is the time for all departments to unite. With UICC’s breast cancer project and WHO Organized by the Global Breast Cancer Initiative, there is an incentive to encourage true multi-stakeholders to cooperate and implement effective strategies to deal with breast cancer. By encouraging and promoting early detection programs that adapt to the level of resources of a country, as well as caring for patients with advanced breast cancer and the most The needs of vulnerable people make it urgent to transform consciousness into action.”
Julie Rihani, a breast cancer survivor and patient advocate, said: “I don’t want to just fail to progress. I want to live long.”
Novartis is constantly striving to reimagine medicine and transform cancer care, giving priority to providing innovative targeted treatments for breast cancer to extend and change the lives of patients. By working with different stakeholders, Novartis will demonstrate their ambitions to change lives, improve patient outcomes, rekindle patients’ hopes for the future, emphasize the importance of overall survival, and become a trusted partner in changing medical practice.
*refer to: https://www.who.int/news-room/fact-sheets/detail/breast-cancer
Oct/2021/BC/1/PR/GC2110074262
[ad_2]
Source link